These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3436 related items for PubMed ID: 12874023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 3. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J.
    Cancer Res; 2003 Feb 01; 63(3):664-73. PubMed ID: 12566312
    [Abstract] [Full Text] [Related]

  • 4. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
    Li J, Cui G, Sun L, Wang SJ, Li YL, Meng YG, Guan Z, Fan WS, Li LA, Yang YZ, You YQ, Fu XY, Yan ZF, Huang K.
    Oncol Rep; 2013 Jul 01; 30(1):165-70. PubMed ID: 23604529
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G, Berenguer J, Borczuk AC, Powell CA, Hei TK, Zhao Y.
    Cancer Res; 2006 May 01; 66(9):4566-73. PubMed ID: 16651406
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation of ARHI in breast and ovarian cancer cells.
    Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, Bast RC.
    Ann N Y Acad Sci; 2003 Mar 01; 983():268-77. PubMed ID: 12724231
    [Abstract] [Full Text] [Related]

  • 7. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers.
    Liu X, Zhang T, Li Y, Zhang Y, Zhang H, Wang X, Li L.
    Adv Exp Med Biol; 2020 Mar 01; 1255():123-132. PubMed ID: 32949395
    [Abstract] [Full Text] [Related]

  • 8. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q.
    Oncogene; 2004 Jun 10; 23(27):4793-806. PubMed ID: 15122337
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.
    Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468
    [Abstract] [Full Text] [Related]

  • 10. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 19; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 11. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD.
    Cancer Res; 2001 May 01; 61(9):3581-5. PubMed ID: 11325823
    [Abstract] [Full Text] [Related]

  • 12. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI.
    Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC, Yu Y.
    Biochim Biophys Acta; 2001 Jun 28; 1519(3):216-22. PubMed ID: 11418188
    [Abstract] [Full Text] [Related]

  • 13. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
    Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S.
    Cancer Res; 2001 Nov 15; 61(22):8094-9. PubMed ID: 11719434
    [Abstract] [Full Text] [Related]

  • 14. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.
    Cancer Res; 2001 Mar 01; 61(5):2320-7. PubMed ID: 11280805
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC.
    Gastroenterology; 2006 Dec 01; 131(6):1835-43. PubMed ID: 17087954
    [Abstract] [Full Text] [Related]

  • 19. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W, Lu Z, Luo RZ, Zhang X, Seto E, Liao WS, Yu Y.
    Int J Cancer; 2007 Apr 15; 120(8):1664-8. PubMed ID: 17230502
    [Abstract] [Full Text] [Related]

  • 20. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.
    Cancer Res; 2002 Jul 01; 62(13):3698-701. PubMed ID: 12097277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 172.